Glaukos (GKOS)
(Delayed Data from NYSE)
$119.29 USD
+0.31 (0.26%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $119.29 0.00 (0.00%) 4:26 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
GKOS 119.29 +0.31(0.26%)
Will GKOS be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for GKOS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GKOS
Here's Why You Should Retain Glaukos (GKOS) Stock for Now
Glaukos (GKOS) Reaches 52-Week High: What's Driving the Stock?
GKOS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Glaukos (GKOS) Stock Jumps 3.7%: Will It Continue to Soar?
Why Is Waters (WAT) Down 5.1% Since Last Earnings Report?
Glaukos (GKOS) Gains 40.4% YTD: What's Driving the Rally?
Other News for GKOS
Glaukos Announces Agreements to Exchange $230 Million in Principal Amount of Its 2.75% Convertible Senior Notes Due 2027 for Common Stock
4 constructive medical devices stocks - BTIG
Glaukos Governance and Compensation Strategy Evolves
Glaukos price target raised by $20 at Stifel, here's why
Glaukos Reaches Analyst Target Price